1. Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response
- Author
-
David W. Threadgill, W. Kimryn Rathmell, and Michelle C. DeSimone
- Subjects
Cancer Research ,endocrine system diseases ,Tumor suppressor gene ,DNA damage ,Ubiquitin-Protein Ligases ,Cell Cycle Proteins ,Ataxia Telangiectasia Mutated Proteins ,Protein Serine-Threonine Kinases ,urologic and male genital diseases ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Animals ,Humans ,Point Mutation ,Missense mutation ,neoplasms ,Carcinoma, Renal Cell ,030304 developmental biology ,0303 health sciences ,biology ,Tumor Suppressor Proteins ,Point mutation ,Teratoma ,medicine.disease ,Molecular biology ,female genital diseases and pregnancy complications ,Kidney Neoplasms ,Trichloroethylene ,3. Good health ,Ubiquitin ligase ,DNA-Binding Proteins ,Clear cell renal cell carcinoma ,HIF1A ,Oncology ,Proteasome ,Von Hippel-Lindau Tumor Suppressor Protein ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Hypoxia-Inducible Factor 1 ,DNA Damage - Abstract
Epidemiological studies have linked exposure to trichloroethylene (TCE), an organic solvent classified as a group 1 carcinogen and recognized contaminant in groundwater, with increased incidences of clear cell renal cell carcinoma (ccRCC). A tumor-specific somatic C454T missense mutation in the von Hippel-Lindau tumor suppressor gene (VHL) has been linked with TCE-associated ccRCC cases (1,2). This mutation results in a single amino acid change from proline to serine at codon 81 of the VHL protein (P81S) and is observed in more than 39% of TCE-exposed individuals who developed ccRCC (1). The VHL tumor suppressor functions as a redox sensor, controlling stability of the hypoxia-inducible transcription factor family (HIFs). VHL forms a complex with Elongin B (TCEB2), Elongin C (TCEB1), Ringbox1 (RBX1), and Cullin2 (CUL2) to form an E3 ubiquitin ligase complex (VBC complex) (3). Under normal oxygen conditions, oxygen-dependent prolyl-hydroxylase (PHD) enzymes hydroxylate HIF proteins at two specific proline residues that are recognized by VHL, and the VBC complex then polyubiquitinates HIF for degradation by the 26S proteasome (4). Cancer-associated missense mutations in VHL disrupt its function in the E3 ubiquitin ligase complex, resulting in variable deregulation of HIF factors (5,6). Structural models of molecular interactions between VHL and TCEB1 showed codons 81 and 82 of VHL are direct TCEB1 binding sites, suggesting that the P81S mutation associated with TCE exposure could destabilize the VBC complex and result in HIF-mediated transcriptional activation of hypoxia response targets (7). The HIF family members (HIF1A and HIF2A) play a central role in metabolic reprogramming observed in human renal tumors, which is thought to provide a selective survival advantage in changing microenvironments by modifying energy use during periods of hypoxic and glycolytic stress (8). This diversification of energy sources through increased glycolysis (the Warburg Effect) (9), fatty acid oxidation (10,11), and glutaminolysis (12–14) can promote cell proliferation and, in some cases, resistance to chemotherapeutic-induced apoptosis (15). HIF activation and metabolic changes have also been implicated as a result of Ataxia Telangiectasia Mutated (ATM) activation, a protein kinase involved in the response to DNA damage (16,17). Although HIF activation suggests a possible link between ATM-mediated DNA damage response and VHL, this has not been previously detected. In this study, the TCE-associated P81S VHL mutation was modeled and its activity compared with cells expressing normal VHL and the hotspot R167Q VHL mutant that was previously shown to dysregulate both HIF factors in graded fashion (5,6,18). The results show that the unique TCE-associated VHL mutation has pleiotropic effects that selectively influence the tumor behavior in a mutation-specific manner, providing a selective growth advantage through metabolic diversification, apoptosis suppression, and alteration of the DNA damage response.
- Published
- 2013
- Full Text
- View/download PDF